Profile
Mr. Jack Barbut is on the Board of Directors at Novimmune SA.
Mr. Barbut was previously employed as President & Chief Executive Officer by SYNARC, Inc. and President & Founder by Chrysalis International Corp.
He received his graduate degree from École Polytechnique Fédérale de Lausanne.
Former positions of Jack Barbut
| Companies | Position | End |
|---|---|---|
Synexus Compass, Inc.
 Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA. | President | 01/01/2000 |
Chrysalis International Corp.
 Chrysalis International Corp. Pharmaceuticals: MajorHealth Technology Chrysalis International Corp. provides drug development services to the pharmaceutical and biotechnology industries. Its services include transgenic discovery research, preclinical development and clinical capabilities. The company was founded in 1988 and is headquartered in Raritan, NJ. | Founder | 01/01/1998 |
| NOVIMMUNE SA | Chief Executive Officer | - |
Training of Jack Barbut
| École Polytechnique Fédérale de Lausanne | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
Synexus Compass, Inc.
Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA. | Health Services |
Chrysalis International Corp.
Chrysalis International Corp. Pharmaceuticals: MajorHealth Technology Chrysalis International Corp. provides drug development services to the pharmaceutical and biotechnology industries. Its services include transgenic discovery research, preclinical development and clinical capabilities. The company was founded in 1988 and is headquartered in Raritan, NJ. | Health Technology |
- Stock Market
- Insiders
- Jack Barbut
